CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kingworld Medicines Group Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kingworld Medicines Group Ltd
10F, Block A, Tian An International Bldg
Renmin South Road
Phone: +86 75582292888p:+86 75582292888 SHENZHEN, GNG  518016  China Ticker: 11101110
Business Summary
Kingworld Medicines Group Ltd is an investment holding company primarily engaged in the distribution sale of branded imported pharmaceutical and healthcare products. The Company operates its business through two segments. The Distribution Sales of Pharmaceutical and Health Care Products segment engages in distribution and sales of branded imported pharmaceutical and healthcare products. The Company’s distribution products include Nin Jiom Pei Pa Koa, Taiko Seirogan, Culturelle Probiotics and other products. The Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segment engages in the manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices. The Company’s medical devices and equipment products include infrared thermometers, handheld electrophysical therapeutic products and other products. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
3841 Surgical and medical instruments and apparatus
5499 Miscellaneous food stores
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer Li ShengZhao 63 1/1/2015 9/25/2008
Financial Controller, Company Secretary, Authorised Representative Hon WanChan 61 6/25/2009 6/25/2009
Executive Director Lok SanChan 58 9/25/2008 9/25/2008
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 927 (As of 6/30/2024)
Outstanding Shares: 622,500,000 (As of 6/30/2024)
Stock Exchange: HKG
Fax Number: +86 75582170669


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024